SHANTI PHILIP: Open Payments
NPI 1861873754 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$681 in 22 payments from 10 companies in 2025. Trend: 2023 $769 · 2024 $700 · 2025 $681
Food & beverage: $681
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $133 |
| Syndax Pharmaceuticals, Inc. | 4 | $131 |
| Incyte Corporation | 4 | $115 |
| SOBI, INC | 2 | $75 |
| Astellas Pharma US Inc | 2 | $65 |
| Celgene Corporation | 2 | $55 |
| ABBVIE INC. | 1 | $33 |
| Rigel Pharmaceuticals, Inc. | 1 | $32 |
| Merck Sharp & Dohme LLC | 1 | $29 |
| Lilly USA, LLC | 1 | $15 |
Products named: CALQUENCE, JAKAFI, REBLOZYL, Vonjo, Cresemba, EPKINLY, TAVALISSE, JAYPIRCA.
Industry payments across TX — which companies pay providers there.
